CRISM Therapeutics Corporation Cash Flow Quality Index
CRISM Therapeutics Corporation cash flow quality index. CRISM Therapeutics Corporation (CRTX) has a Cash Flow Quality Index of -4.43x as of June 2021. Operating cash flow of GBX-1.04 Million is below net income of GBX234.81K, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is CRISM Therapeutics Corporation to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CRISM Therapeutics Corporation Cash Flow Quality Index by Year (None–None)
CRISM Therapeutics Corporation cash flow quality index by year from None to None. Year-by-year earnings quality comparison for CRISM Therapeutics Corporation. For the full cash flow conversion analysis, see CRTX cash flow conversion.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|